CIC BiomaGUNE
Centro
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (9)
2022
-
Shiga Toxin-B Targeted Gold Nanorods for Local Photothermal Treatment in Oral Cancer Clinical Samples
International journal of nanomedicine, Vol. 17, pp. 5747-5760
2020
-
Epitopes for Multivalent Vaccines Against Listeria, Mycobacterium and Streptococcus spp: A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase
Frontiers in Cellular and Infection Microbiology, Vol. 10
2019
-
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
OncoImmunology, Vol. 8, Núm. 2
2018
-
Reduction of cardiac TGFβ-mediated profibrotic events by inhibition of Hsp90 with engineered protein
Journal of Molecular and Cellular Cardiology, Vol. 123, pp. 75-87
2017
-
GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination
Oncotarget, Vol. 8, Núm. 33, pp. 53916-53934
-
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma
Nanoscale, Vol. 9, Núm. 30, pp. 10721-10732
2016
-
Extracellular heat shock protein 90 binding to TGFβ receptor I participates in TGFβ-mediated collagen production in myocardial fibroblasts
Cellular Signalling, Vol. 28, Núm. 10, pp. 1563-1579
-
Pregnancy vaccination with gold glyco-nanoparticles carrying Listeria monocytogenes peptides protects against listeriosis and brain- and cutaneous-associated morbidities
Nanomaterials, Vol. 6, Núm. 8
2015
-
Novel nanoparticle vaccines for listeriosis
Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 10, pp. 2501-2503